Springer signs agreement with ISOBM to co-publish the journal Tumor Biology

Tumor Biology to strengthen Springer's biomedicine portfolio

Springer, a leading publisher in the fields of science, technology and medicine, has signed an agreement with the International Society of Oncology and BioMarkers (ISOBM) to co-publish the journal Tumor Biology starting in January 2010. Tumor Biology was founded by the ISOBM in 1980 as Oncodevelopmental Biology and Medicine. It will be published at Springer six times a year electronically and in print.

Tumor Biology publishes original research, mini-reviews and commentaries on translational cancer research. The journal places special emphasis on articles covering all aspects of tumor markers and tumor targeting, but studies in other areas of clinical and translational cancer research are included as well. Following a multidisciplinary approach, Tumor Biology provides an important platform for cell and molecular biologists, developmental biologists, pathologists, clinical oncologists and any researcher involved in the study of tumors. The editor-in-chief is Professor Torgny Stigbrand from Ume- University, Ume-, Sweden.

Dr. Petra Stieber, President of ISOBM, said, "Tumor biology is the major target for research to elucidate mechanisms behind tumor formation and may contribute to minimize consequences of malignant diseases for patients. It is a true pleasure to work with a worldwide-recognized publisher and we look forward to a long and fruitful collaboration with Springer."

Peter Butler, Editorial Director of Biomedicine and Life Sciences at Springer, said, "We are delighted to be able to join forces with the ISOBM and Professor Stigbrand. We look forward to developing the content of Tumor Biology further and to increasing the journal's visibility through the global reach of SpringerLink."